Dr. Raquel Perez-Lopez is an experienced academic radiologist trained in Barcelona, Spain, and at the Royal Marsden Hospital and the Institute of Cancer Research in London, UK. She completed a Master's degree in Medical Research at the University of Barcelona. Her PhD studies enabled her to identify the value of whole-body diffusion-weighted MRI as a prognostic and response biomarker of bone metastases in prostate cancer, which subsequently led to the successful completion of the first prospective clinical trial in this context.

In late 2017, Raquel joined VHIO as the Team Leader of VHIO’s Radiomics Group. Her expertise focuses on precision imaging in personalized medicine, achieved through the application of mathematical methods to image processing and harnessing the potential of AI in oncology. She is also involved as an investigator in several European research initiatives, including CCE-DART, ODELIA, and TANGERINE. Additionally, she holds editorial roles for npj Precision Oncology, ESMO Real World Data and Digital Oncology, as well as Scientific Reports, and leads the Cancer Core Europe Imaging Task Force.